Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
| ▸ | LAP3 | P28838 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL923636 | 0.83 | CYP3A4 (0.53) | MEN1KMT2AHPGDKDM4ELMNA | |
| SCHEMBL3628765 | 0.81 | AOX1 (0.49) | L3MBTL1SRCTDP1PKMMEN1 | |
| SCHEMBL4452184 | 0.80 | SRC (0.48) | L3MBTL1SRCTDP1MEN1KMT2A | |
| SCHEMBL5483772 | 0.78 | L3MBTL1 (0.55) | L3MBTL1SRCTDP1PKMMEN1 | |
| SCHEMBL5491492 | 0.74 | L3MBTL1 (0.52) | L3MBTL1SRCTDP1PKMMEN1 | |
| SCHEMBL922430 | 0.74 | TSHR (0.52) | SRCPKMKDM4E | |
| SCHEMBL14439890 | 0.73 | L3MBTL1 (0.46) | L3MBTL1SRCTDP1PKMMEN1 | |
| SCHEMBL676524 | 0.72 | SRC (0.58) | L3MBTL1SRCTDP1PKMMEN1 | |
| SCHEMBL310184 | 0.72 | SRC (0.58) | L3MBTL1SRCTDP1PKMMEN1 | |
| SCHEMBL5490967 | 0.72 | L3MBTL1 (0.49) | L3MBTL1SRCTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2138502-B1 | PROCESS FOR PRODUCING PHOSPHORUS-CONTAINING DEHYDROAMINO ACID | MEIJI SEIKA PHARMA CO LTD (JP) | 2014-02-19 | — | — | EP | disclosed |
| US-8329935-B2 | Process for producing phosphorus-containing dehydroamino acid | MEJI SEIKA KAISHA LTD. (JP) | 2012-12-11 | — | — | US | disclosed |
| CN-101636402-B | Method for producing phosphorus-containing dehydroamino acid | MEIJI SEIKA KAISHA JP | 2012-04-18 | — | — | CN | disclosed |
| US-20110009662-A1 | PROCESS FOR PRODUCING PHOSPHORUS-CONTAINING DEHYDROAMINO ACID | MEIJI SEIKA KAISHA LTD. (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-2138502-A1 | PROCESS FOR PRODUCING PHOSPHORUS-CONTAINING DEHYDROAMINO ACID | Meiji Seika Kaisha Ltd. (JP) | 2009-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009662-A1 | PROCESS FOR PRODUCING PHOSPHORUS-CONTAINING DEHYDROAMINO ACID | AMPD2, AMPD1, AMPD3 | L3MBTL1 929/4885SRC 3364/4885TDP1 2725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.